Eating DisordersSensoryCopNCT07031037
Exploratory Study of Sensory Profile and Coping Strategies in Eating Disorders
An observational study of Eating Disorders and Anorexia Nervosa, run by Centre Hospitalier Esquirol at 1 site in France.
Trial summary
This descriptive study aims primarily to characterize the sensory profile of patients with eating disorders (divided into three diagnostic groups: anorexia nervosa, boulimia nervosa and hyperphagia), controlling for possible autistic traits in this population. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Eating Disorders, Anorexia Nervosa, Boulimia Nervosa
- What is being tested?
- Scales
- How many people
- 150 participants
- Where
- 1 siteFrance
- Study dates
- 11 May 2026to Jun 2029
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Participants will be enrolled during hospitalization or consultation of their Eating Disorder treatment in the Esquirol Hospital Center of Limoges, France.
Who may be able to join
- Gender and Age: Male or female, aged 18 to 65
- Confirmed diagnosis of anorexia nervosa (F50.01; F50.02), boulimia nervosa (F50.2), hyperphagic episodes (F50.8) or restriction or avoidance of food intake (F50.8) according to DSM-5 criteria
- Hospitalization or consultation for Eating Disorder at Centre Hospitalier Esquirol
- Consent: Free, informed, and written consent, signed by the participant and/or their legal representative (for participants under protection measures) and the investigator (at the latest on the day of inclusion and before any research-related examination).
Who cannot join
- Psychiatric comorbidity (non-tobacco addiction, characterized depressive episode, bipolar disorder, obsessive-compulsive disorder, schizophrenia and related disorders, neurodevelopmental disorder)
- History of Eating Disorder other than current disorder
- Proven sensory or neurological disability
- Inability to understand questionnaires and information related to the study
- Persons under psychiatric care in accordance with articles L. 3212-1 and L. 3213-1
- Pregnant, nursing or parturient women
Show all 9Show fewer
- Adults subject to legal protection or unable to express their consent to express their consent
- Persons not affiliated to a social security scheme or not benefiting from one social security scheme
- Persons deprived of their liberty by judicial or administrative decision
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Esquirol Hospital Center
Limoges, New Aquitaine, 87025
Alexandra Foucher, University degree, +33 5-55-43-11-00, alexandra.foucher@ch-esquirol-limoges.fr
Aude Paquet, PhD in Psychology
About this study
This descriptive study aims primarily to characterize the sensory profile of patients with eating disorders (divided into three diagnostic groups: anorexia nervosa, boulimia nervosa and hyperphagia), controlling for possible autistic traits in this population.
The study involves measuring characteristics associated with eating disorders (diagnosis, BMI, anxiety), assessing the sensory profile (AASP), and coping strategies in patients with eating disorders who are hospitalised or followed up in consultation.
- Conditions
- Eating Disorders, Anorexia Nervosa, Boulimia Nervosa, Hyperphagia
- Being tested
- Scales
- Keywords
- Sensory Profile, Coping Strategies, Eating Disorders, sensory processing disorder
- Medical subject headings
- Feeding and Eating Disorders, Anorexia Nervosa, Hyperphagia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ScalesOther
Five questionnaires were administered at inclusion, socio-demographic and clinical data were collected during an interview (anxiety-depression, treatments).
The following questionnaires were used: The Revised Ritvo Autism and Asperger Diagnostic Scale (RAADS-R-Fr), the Eating Disorder Examination Self-Report Questionnaire (EDE-Q), the Adolescent/Adult Sensory Profile (AASP), the Coping Inventory for Stressful Situations (CISS), the Hospital anxiety and depression scale (HAD) and the Multidimensional Assessment of Interoceptive Awareness Version 2 (MAIA-2).
What is being measured
The primary outcome is the main question the study is designed to answer.
Sensory profile from the Adolescent and Adult Sensory Profile (Brown and Dunn, 2002) according to each diagnostic group.
Sensory profile scores will be obtained using the Adolescent and Adult Sensory Profile (AASP) scale during an individual interview after the participant has been included in the study. Subscores for sensory sensitivity, low registration, sensation seeking, and sensation avoidance will be collected. For each subscore, the minimum and maximum values range from 15 to 75. A high score indicates high sensory sensitivity.
Measured: At enrollment
Scores for task coping drawn from the Coping Inventory for Stressful Situations (Endler & Parker, adapted by JP Rolland) according to each diagnostic group
Coping scores will be obtained using the Coping Inventory for Stressful Situations (CISS) scale during an individual interview after the participant has been included in the study. The task-oriented coping subscore, emotion subscore, avoidance subscore, distraction subscore, and social diversion subscore will be collected. The minimum and maximum values range from 16 to 90. A high score indicates high oriented coping.
Measured: at enrollment
Secondary outcomes (4)
Description of the frequency of autistic traits for each diagnostic group
The frequency of autistic traits will be obtained using the Revised Ritvo Autism and Asperger Diagnostic Scale (RAADS-R-Fr) during an individual interview after the participant has been included in the study. The minimum and maximum values range from 0 to 240. The generally accepted threshold for significant autistic traits is 70. A high score indicate high autistic traits.
Measured: At enrollment
Description of the frequency of eating disorders for each diagnostic group.
Eating disorders will be assessed using the Eating Disorder Examination Self-Report Questionnaire (EDE-Q) during an individual interview after the participant's inclusion. The EDE-Q, provide subscale scores reflecting the severity of aspects of the psychopathology of eating disorders. The subscales are Restraint, Eating Concern, Shape Concern and Weight Concern. For Restaint subscale minimum and maximum values range from 0 to 30. For Eating Concern subscale minimum and maximum values range from 0 to 30. For Shape Concern subscale minimum and maximum values range from 0 to 48. For Weight Concern subscale minimum and maximum values range from 0 to 30.
The higher the score, the more severe the symptoms.
Measured: At enrollment
Anxiety according to each diagnostic group.
Anxiety and depression will be obtained using the Hospital Anxiety and Depression Scale (HAD) during an individual interview after the participant's inclusion. The anxiety subscore will be collected. Minimum and maximum values range from 0 to 21. The generally accepted threshold for significant anxiety is 11.
Measured: At enrollment
Body awareness from the multidimensional assessment of interoceptive awareness for each diagnostic group.
Body awareness will be obtained using the Multidimensional Assessment of Interoceptive Awareness Version 2 (MAIA-2) scale during an individual interview after the participant's inclusion. Minimum and maximum values range from 0 to 185. A high score indicates high interoceptive awareness.
Measured: At enrollment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jun 2025
- Study start11 May 2026
- Primary completion11 May 2029 (estimated)
- Study completionJun 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Eating DisordersStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 150 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Esquirol
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aude Paquet, Centre Hospitalier Esquirol
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07031037
- Sponsor's protocol ID
- 2024-A01154-43
- Acronym
- SensoryCop
- Status last verified
- Oct 2026
- First submitted
- 14 May 2025
- Last updated
- 30 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Exploratory Study of Sensory Profile and Coping Strategies in Eating Disorders
- ClinicalTrials.gov ID
- NCT07031037
- Acronym / sponsor ID
- SensoryCop / 2024-A01154-43
- Conditions
- Eating Disorders, Anorexia Nervosa, Boulimia Nervosa, Hyperphagia
- Keywords
- Sensory Profile, Coping Strategies, Eating Disorders, sensory processing disorder
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 150 participants (estimated)
- Lead sponsor
- Centre Hospitalier EsquirolUniversity, hospital or other
- Study start
- 11 May 2026 (actual)
- Primary completion
- 11 May 2029 (estimated)
- Study completion
- Jun 2029 (estimated)
- First posted
- 22 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This descriptive study aims primarily to characterize the sensory profile of patients with eating disorders (divided into three diagnostic groups: anorexia nervosa, boulimia nervosa and hyperphagia), controlling for possible autistic traits in this population.
The study involves measuring characteristics associated with eating disorders (diagnosis, BMI, anxiety), assessing the sensory profile (AASP), and coping strategies in patients with eating disorders who are hospitalised or followed up in consultation.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Participants will be enrolled during hospitalization or consultation of their Eating Disorder treatment in the Esquirol Hospital Center of Limoges, France.
Key inclusion criteria (4 listed)
- Gender and Age: Male or female, aged 18 to 65
- Confirmed diagnosis of anorexia nervosa (F50.01; F50.02), boulimia nervosa (F50.2), hyperphagic episodes (F50.8) or restriction or avoidance of food intake (F50.8) according to DSM-5 criteria
- Hospitalization or consultation for Eating Disorder at Centre Hospitalier Esquirol
- Consent: Free, informed, and written consent, signed by the participant and/or their legal representative (for participants under protection measures) and the investigator (at the latest on the day of inclusion and before any research-related examination).
Key exclusion criteria (9 listed)
- Psychiatric comorbidity (non-tobacco addiction, characterized depressive episode, bipolar disorder, obsessive-compulsive disorder, schizophrenia and related disorders, neurodevelopmental disorder)
- History of Eating Disorder other than current disorder
- Proven sensory or neurological disability
- Inability to understand questionnaires and information related to the study
- Persons under psychiatric care in accordance with articles L. 3212-1 and L. 3213-1
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ScalesFive questionnaires were administered at inclusion, socio-demographic and clinical data were collected during an interview (anxiety-depression, treatments). The following questionnaires were used: The Revised Ritvo Autism and Asperger Diagnostic Scale (RAADS-R-Fr), the Eating Disorder Examination Self-Report Questionnaire (EDE-Q), the Adolescent/Adult Sensory Profile (AASP), the Coping Inventory for Stressful Situations (CISS), the Hospital anxiety and depression scale (HAD) and the Multidimensional Assessment of Interoceptive Awareness Version 2 (MAIA-2). | Other | – |
Primary outcome
Sensory profile from the Adolescent and Adult Sensory Profile (Brown and Dunn, 2002) according to each diagnostic group.
Time frame: At enrollment
Sensory profile scores will be obtained using the Adolescent and Adult Sensory Profile (AASP) scale during an individual interview after the participant has been included in the study. Subscores for sensory sensitivity, low registration, sensation seeking, and sensation avoidance will be collected. For each subscore, the minimum and maximum values range from 15 to 75. A high score indicates high sensory sensitivity.
Scores for task coping drawn from the Coping Inventory for Stressful Situations (Endler & Parker, adapted by JP Rolland) according to each diagnostic group
Time frame: at enrollment
Coping scores will be obtained using the Coping Inventory for Stressful Situations (CISS) scale during an individual interview after the participant has been included in the study. The task-oriented coping subscore, emotion subscore, avoidance subscore, distraction subscore, and social diversion subscore will be collected. The minimum and maximum values range from 16 to 90. A high score indicates high oriented coping.
4 secondary outcomes
Description of the frequency of autistic traits for each diagnostic group
Time frame: At enrollment
Description of the frequency of eating disorders for each diagnostic group.
Time frame: At enrollment
Anxiety according to each diagnostic group.
Time frame: At enrollment
Body awareness from the multidimensional assessment of interoceptive awareness for each diagnostic group.
Time frame: At enrollment
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Eating Disorders
Not yet recruiting
Be Body Brave: Digital Written Exposure Therapy for Eating Disorders
Eating Disorders
Enrolling by invitationPhase 3
A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating Disorder
Binge-Eating Disorder
Recruiting
An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being
Excessive Gestational Weight Gain, Pregnancy
Not yet recruiting
Compulsive Eating and Brain's Reward System in Different Pathologies
PARKINSON DISEASE (Disorder), Bipolar 1 Disorder
Not yet recruitingObservational study
Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism
Healthy Volunteer, Obestity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Eating Disorders and Anorexia Nervosa, run by Centre Hospitalier Esquirol at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 30 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Aude Paquet, PhD in Psychology (+33 5-55-43-11-27, aude.paquet@ch-esquirol-limoges.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sensory profile from the Adolescent and Adult Sensory Profile (Brown and Dunn, 2002) according to each diagnostic group. (time frame: At enrollment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2026.